Suchergebnisse - "Hu, Dennis X"

PubPharm (46)

1

Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy

enthalten in: Journal of medicinal chemistry | 2022

von Jackson, J. | Shibuya, G. | Ravishankar, B. | +36

2

Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors

enthalten in: Journal of medicinal chemistry | 2022

von Hu, D. | Patel, S. | Chen, H. | +21

3

AZETIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

enthalten in: Europäisches Patentamt | 2022

von BECK HILARY PLAKE | BIANNIC BERENGER | BUI MINNA HUE THANH | +11

4

AZETIDINE DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

enthalten in: Europäisches Patentamt | 2022

von BECK HILARY PLAKE | BIANNIC BERENGER | BUI MINNA HUE THANH | +11

5

CHEMOKINE RECEPTOR MODULATORS AND USE THEREOF

enthalten in: Europäisches Patentamt | 2022

von BECK HILARY PLAKE | BIANNIC BERENGER | BUI MINNA HUE THANH | +11

6

CHEMOKINE RECEPTOR MODULATORS AND USE THEREOF

enthalten in: Europäisches Patentamt | 2022

von BECK HILARY PLAKE | BIANNIC BERENGER | BUI MINNA HUE THANH | +11

7

EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22

enthalten in: PLoS pathogens | 2022

von Jorapur, A. | Marshall, L. | Jacobson, S. | +13

8

Chemokine receptor modulators and uses thereof

enthalten in: Europäisches Patentamt | 2021

von BECK HILARY PLAKE | BIANNIC BERENGER | BUI MINNA HUE THANH | +11

9

Ubiquitin-specific-processing protease 7 (USP7) modulators and uses thereof

enthalten in: Europäisches Patentamt | 2021

von BIANNIC BERENGER | HAN XINPING | HU DENNIS X | +8

10

Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity In Vitro and In Vivo

enthalten in: Molecular cancer therapeutics | 2020

von Ohol, Y. | Sun, M. | Cutler, G. | +24

1
2
3
4
5
Nächster »
[5]